Abstract

Discovery of a novel anticancer drug delivery agent is important to replace conventional cancer therapies which are often accompanied by undesired side effects. This study demonstrated the synthesis of superparamagnetic magnetite nanocomposites (Fe3O4-NCs) using a green method. Montmorillonite (MMT) was used as matrix support, while Fe3O4 nanoparticles (NPs) and carrageenan (CR) were used as filler and stabilizer, respectively. The combination of these materials resulted in a novel nanocomposite (MMT/CR/Fe3O4-NCs). A series of characterization experiments was conducted. The purity of MMT/CR/Fe3O4-NCs was confirmed by X-ray diffraction (XRD) analysis. High resolution transmission electron microscopy (HRTEM) analysis revealed the uniform and spherical shape of Fe3O4 NPs with an average particle size of 9.3 ± 1.2 nm. Vibrating sample magnetometer (VSM) analysis showed an Ms value of 2.16 emu/g with negligible coercivity which confirmed the superparamagnetic properties. Protocatechuic acid (PCA) was loaded onto the MMT/CR/Fe3O4-NCs and a drug release study showed that 15% and 92% of PCA was released at pH 7.4 and 4.8, respectively. Cytotoxicity assays showed that both MMT/CR/Fe3O4-NCs and MMT/CR/Fe3O4-PCA effectively killed HCT116 which is a colorectal cancer cell line. Dose-dependent inhibition was seen and the killing was enhanced two-fold by the PCA-loaded NCs (IC50–0.734 mg/mL) compared to the unloaded NCs (IC50–1.5 mg/mL). This study highlights the potential use of MMT/CR/Fe3O4-NCs as a biologically active pH-responsive drug delivery agent. Further investigations are warranted to delineate the mechanism of cell entry and cancer cell killing as well as to improve the therapeutic potential of MMT/CR/Fe3O4-NCs.

Highlights

  • Cancer is a primary health problem and it is one of the leading causes of death globally [1]

  • MMT/CR/Fe3O4-NCs were successfully synthesized via a green approach in this study

  • The phase purity of MMT/CR/Fe3O4-NCs was confirmed by X-ray diffraction (XRD) analysis

Read more

Summary

Introduction

Cancer is a primary health problem and it is one of the leading causes of death globally [1]. Some of the examples include application of gold NPs in biosensors for diagnosis of foot and mouth disease virus [9], application of graphene oxide NCs for imaging breast cancer via intratumoral administration [10], and utilization of multifunctional mesoporous silica NPs for cancer-specific drug delivery [11]. Inorganic nanomaterials such as magnetite (Fe3O4) has been widely studied for its biomedical application such as magnetic resonance imaging (MRI) [12], magnetic hyperthermia [13] and drug delivery [14,15]. We evaluated the anticancer action of the MMT/CR/Fe3O4-PCA against the HCT116 colon cancer cell line

Results
Materials
Cell culture
Characterization
Drug Loading
Drug Release Study
Cytotoxicity Assay
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.